Haipeng Xu

Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

Yunhang Guo, Ye Liu, Nan Hu et al. · Journal of Medicinal Chemistry · 2019 · 349 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer

Gen Lin, Xirong Fan, Weifeng Zhu et al. · Oncotarget · 2017 · 84 citations · Full text

Medicine, Oncology, Pathology +17

Comparison of 22C3 PD-L1 Expression between Surgically Resected Specimens and Paired Tissue Microarrays in Non–Small Cell Lung Cancer

Chao Li, Cheng Huang, Tony Mok et al. · Journal of Thoracic Oncology · 2017 · 68 citations · Full text

Medicine, Molecular Biology, Oncology +15

Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma

Gen Lin, C. Li, Peipei Li et al. · Annals of Oncology · 2020 · 50 citations

Medicine, Genetics, Oncology +13

Assessment of Concordance between 22C3 and SP142 Immunohistochemistry Assays regarding PD-L1 Expression in Non-Small Cell Lung Cancer

Haipeng Xu, Cheng Huang, Weifeng Zhu et al. · Scientific Reports · 2017 · 41 citations · Full text

Medicine, Oncology, Pathology +17